Karan Sweta, Choudhury Devapriya, Dixit Aparna
Gene Regulation Laboratory, School of Biotechnology, Jawaharlal Nehru Universitys, New Delhi, 110067, India.
Appl Microbiol Biotechnol. 2021 Jan;105(2):599-616. doi: 10.1007/s00253-020-11038-4. Epub 2021 Jan 6.
Vibrio parahaemolyticus is one of the major pathogens responsible for vibriosis and zoonotic infections in teleosts, marine invertebrates, and also humans through consumption of contaminated or unprocessed seafood. Emergence of resistance against current accessible antibiotics and spread to the food chain and environment necessitate the development of safe and effective subunit vaccine against this bacterium. Many bacteria including V. parahaemolyticus produce extracellular curli fibrils, heteropolymeric filaments of major and minor subunit, which have been implicated in adhesion, biofilm formation, and virulence. Adhesins are the primary contact points with the host which help in establishing infection and colonization. CsgA, an adhesin, is the major structural component of the curli fiber that forms homopolymers of several hundred units. Due to their exposure on the cell surface, the curli fibers are recognized by the host's immune system, would generate high immune response, and therefore can serve as effective vaccine candidate. In the present study, we describe characterization of the csgA gene, and preparation of recombinant soluble CsgA of V. parahaemolyticus (rVpCsgA), and evaluation of its vaccine potential. Immunization of BALB/c mice with the rVpCsgA mounted a strong immune response. Cellular immune assays such as antibody isotyping, in vitro splenocyte proliferation analysis, and cytokine profiling revealed mixed T-helper cell immune response. The anti-rVpCsgA antiserum was agglutination positive and specifically cross-reacted with the curli CsgA present on the outer membrane of V. parahaemolyticus cells, thus demonstrating its neutralization potential. One hundred percent survival of the immunized mice upon challenge with the lethal dosage of the bacterium established that the rVpCsgA could serve as an effective vaccine against the bacterium. KEY POINTS: • Recombinant histidine-tagged CsgA of V. parahaemolyticus, rVpCsgA, was purified. • The rVpCsgA immunization produced mixed immune response and agglutinating antibodies. • Immunization with the rVpCsgA protected mice against V. parahaemolyticus challenge.
副溶血性弧菌是导致硬骨鱼、海洋无脊椎动物发生弧菌病和人畜共患病感染的主要病原体之一,人类通过食用受污染或未加工的海鲜也会感染。对目前可用抗生素产生耐药性并传播到食物链和环境中,这就需要研发针对这种细菌的安全有效的亚单位疫苗。包括副溶血性弧菌在内的许多细菌都会产生细胞外卷曲纤维,这是由主要和次要亚基组成的杂聚丝,与黏附、生物膜形成和毒力有关。黏附素是与宿主的主要接触点,有助于建立感染和定植。CsgA是一种黏附素,是卷曲纤维的主要结构成分,能形成数百个单位的同聚物。由于卷曲纤维暴露在细胞表面,会被宿主免疫系统识别,产生高免疫反应,因此可作为有效的疫苗候选物。在本研究中,我们描述了副溶血性弧菌csgA基因的特征、重组可溶性副溶血性弧菌CsgA(rVpCsgA)的制备及其疫苗潜力评估。用rVpCsgA免疫BALB/c小鼠引发了强烈的免疫反应。细胞免疫分析,如抗体分型、体外脾细胞增殖分析和细胞因子谱分析,显示出混合的辅助性T细胞免疫反应。抗rVpCsgA抗血清凝集呈阳性,并与副溶血性弧菌细胞外膜上的卷曲CsgA发生特异性交叉反应,从而证明了其中和潜力。用致死剂量的细菌攻击后,免疫小鼠的存活率为100%,这表明rVpCsgA可作为针对该细菌的有效疫苗。要点:• 纯化了重组组氨酸标记的副溶血性弧菌CsgA,即rVpCsgA。• rVpCsgA免疫产生了混合免疫反应和凝集抗体。• 用rVpCsgA免疫可保护小鼠免受副溶血性弧菌的攻击。